AAAAAA

   
Results: 1-13 |
Results: 13
MEDIASTINAL LARGE-CELL LYMPHOMA WITH SCLEROSIS REFRACTORY TO CONVENTIONAL CHEMOTHERAPY CAN RESPOND AFTER DAILY ORAL CYCLOPHOSPHAMIDE
Authors: BENBOUBKER L LINASSIER C DELAIN M DEMURET A CALAIS G DEQUIN PF LAMAGNERE JP COLOMBAT P
Citation: L. Benboubker et al., MEDIASTINAL LARGE-CELL LYMPHOMA WITH SCLEROSIS REFRACTORY TO CONVENTIONAL CHEMOTHERAPY CAN RESPOND AFTER DAILY ORAL CYCLOPHOSPHAMIDE, Leukemia & lymphoma, 29(1-2), 1998, pp. 199-203
PROTEINACEOUS DEPOSITS AND LIPIDIC HISTIOCYTOSIS IN FOLLICULAR LYMPHOMA
Authors: LEFRANCQ T MICHALAK S BENBOUBKER L
Citation: T. Lefrancq et al., PROTEINACEOUS DEPOSITS AND LIPIDIC HISTIOCYTOSIS IN FOLLICULAR LYMPHOMA, Histopathology, 32(5), 1998, pp. 480-481
HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN - RESULTS OF THE FRENCH RETROSPECTIVE STUDY
Authors: MALOISEL F BENBOUBKER L CARCEL C LEDERLIN P SEDILLOT M RAPP MJ GARDEMBAS M GANHDOUR C BLANC M CHRISTIAN B CASTAIGNE S CHERON N CHAUVENET L DREYFUSS B SALLES B MOREAU P PEGOURIE B OBERLING F
Citation: F. Maloisel et al., HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN - RESULTS OF THE FRENCH RETROSPECTIVE STUDY, British Journal of Haematology, 102(1), 1998, pp. 191-191
PROGNOSTIC FACTORS AND SURVIVAL IN ELDERLY PATIENTS WITH MULTIPLE-MYELOMA
Authors: RODON P GAUVAIN JB LINASSIER C BENBOUBKER L LEVALLOIS D MAIGRE M GOUPILLE P LUTHIER F LUCAS V DUGAY J COLOMBAT P
Citation: P. Rodon et al., PROGNOSTIC FACTORS AND SURVIVAL IN ELDERLY PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 354-354
LONG-TERM FOLLOW-UP OF MARROW PROGENITOR RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD GRAFTS
Authors: BENBOUBKER L DOMENECH J DELAIN M PICHON E BREMOND JL LINASSIER C COLOMBAT P BINET C
Citation: L. Benboubker et al., LONG-TERM FOLLOW-UP OF MARROW PROGENITOR RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD GRAFTS, Experimental hematology, 25(8), 1997, pp. 289-289
HEMATOPOIESIS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH MARROW OR BLOOD GRAFTS - COMPARISON OF LONG-TERM MARROW PROGENITOR RECOVERIES
Authors: BENBOUBKER L DOMENECH J DELAIN M PICHON E BREMOND JL LINASSIER C COLOMBAT P BINET C
Citation: L. Benboubker et al., HEMATOPOIESIS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH MARROW OR BLOOD GRAFTS - COMPARISON OF LONG-TERM MARROW PROGENITOR RECOVERIES, Blood, 90(10), 1997, pp. 4152-4152
THYMIDINE KINASE SERUM LEVEL IS A PREDICTIVE FACTOR FOR RESPONSE AND RELAPSE RATES AFTER FIRST LINE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS
Authors: BENBOUBKER L PICHON E LINASSIER C DELAIN M VALAT C FETISSOF F TELLIER Z LAMAGNERE JP COLOMBAT P
Citation: L. Benboubker et al., THYMIDINE KINASE SERUM LEVEL IS A PREDICTIVE FACTOR FOR RESPONSE AND RELAPSE RATES AFTER FIRST LINE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS, Blood, 90(10), 1997, pp. 1499-1499
S-CA125 AND LDH LEVELS AS A NEW PROGNOSTIC INDEX IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS
Authors: BENBOUBKER L LINASSIER C OLLIVIER I DELAIN M VALAT C FETISSOF F LAMAGNERE JP
Citation: L. Benboubker et al., S-CA125 AND LDH LEVELS AS A NEW PROGNOSTIC INDEX IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 883-883
INTENSIVE THERAPY WITH BEAM AND AUTOLOGOUS STEM-CELL TRANSPLANT IN POOR-RISK HODGKINS-DISEASE - VALUE OF RELAPSE STATUS AND PRETRANSPLANT STATUS FOR PREDICTING OUTCOME
Authors: DELAIN M MAAKHROUN A LINASSIER C BENBOUBKER L LAMAGNERE JP COLOMBAT P BRETONNEAU CHU
Citation: M. Delain et al., INTENSIVE THERAPY WITH BEAM AND AUTOLOGOUS STEM-CELL TRANSPLANT IN POOR-RISK HODGKINS-DISEASE - VALUE OF RELAPSE STATUS AND PRETRANSPLANT STATUS FOR PREDICTING OUTCOME, Experimental hematology, 23(8), 1995, pp. 754-754
LONG-TERM CULTURES TO EVALUATE ENGRAFTMENT POTENTIAL OF CD34(-BLOOD AFTER MOBILIZATION BY CHEMOTHERAPY WITH AND WITHOUT GM-CSF() CELLS FROMPERIPHERAL)
Authors: BENBOUBKER L DOMENECH J LINASSIER C DESBOIS I DELAIN M LAMAGNERE JP COLOMBAT P BINET C
Citation: L. Benboubker et al., LONG-TERM CULTURES TO EVALUATE ENGRAFTMENT POTENTIAL OF CD34(-BLOOD AFTER MOBILIZATION BY CHEMOTHERAPY WITH AND WITHOUT GM-CSF() CELLS FROMPERIPHERAL), Experimental hematology, 23(14), 1995, pp. 1568-1573
RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH VMCP VBAP REGIMEN AS THE INDUCTION-PHASE OF UNTREATED MULTIPLE-MYELOMA - RESULTS OF THE KIF MULTICENTER TRIAL/
Authors: CASASSUS P PEGOURIEBANDELIER B SADOUN A MALOISEL F AUTRAND B BENBOUBKER L QUILICHINI R GARDEMBAS A MAISONNEUVE M PAYEN C FAIN O LAMY T DESABLENS B JANVIER M MAHE B HAROUSSEAU JL
Citation: P. Casassus et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH VMCP VBAP REGIMEN AS THE INDUCTION-PHASE OF UNTREATED MULTIPLE-MYELOMA - RESULTS OF THE KIF MULTICENTER TRIAL/, Blood, 86(10), 1995, pp. 1750-1750
VAD-PECC REGIMEN IN THE TREATMENT OF ADVANCED-STAGE MULTIPLE-MYELOMA
Authors: DELAIN M LINASSIER C PETITDIDIER C GOUPILLE P LUTHIER F COMBE M REISENLEITER M BENBOUBKER L LAMAGNERE JP COLOMBAT P
Citation: M. Delain et al., VAD-PECC REGIMEN IN THE TREATMENT OF ADVANCED-STAGE MULTIPLE-MYELOMA, Journal of clinical oncology, 12(12), 1994, pp. 2706-2713
FAILURE OF ALPHA-INTERFERON TO IMPROVE VMCP VBAP CHEMOTHERAPY RESPONSE RATE IN INDUCTION-PHASE OF UNTREATED MULTIPLE-MYELOMA - RESULTS IN THE 1ST 201 PATIENTS INCLUDED IN A PROSPECTIVE RANDOMIZED STUDY (KIF PROTOCOL)
Authors: CASASSUS P HAROUSSEAU IL MAHE B SADOUN A AUTRAND B BENBOUBKER L QUILICHINI R GARDEMBAS A MAISONNEUVE H SOTTO JJ PAYEN C OBERLING F FAIN O GHANDOUR C LAMY T BATAILLE R
Citation: P. Casassus et al., FAILURE OF ALPHA-INTERFERON TO IMPROVE VMCP VBAP CHEMOTHERAPY RESPONSE RATE IN INDUCTION-PHASE OF UNTREATED MULTIPLE-MYELOMA - RESULTS IN THE 1ST 201 PATIENTS INCLUDED IN A PROSPECTIVE RANDOMIZED STUDY (KIF PROTOCOL), Blood, 84(10), 1994, pp. 10000652-10000652
Risultati: 1-13 |